$LEVI

Haas Robert D. sold $11.9M of LEVI (indirect holdings)

Haas Robert D. sold 492,033 indirectly-held shares of LEVI STRAUSS & CO (LEVI) at an average of $24.10 ($24.00–$24.10, $11.86M total) across 2 trades over 2026-06-10 to 2026-06-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Haas Robert D.
Published Jun 11, 2026, 11:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 11, 2026, 11:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LEVI
Neutral
medium confidence
Mentioned
$LEVI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LEVINeutralLow
01

Why it matters

Traders may treat the disclosure as a sentiment input rather than a fundamental catalyst, given the 10b5-1 pre-arranged nature.

02

Market read

A sizable 10% owner sale ($11.86M) was disclosed, but the pre-arranged 10b5-1 plan suggests limited informational content.

03

What to watch

The filing shows holdings after the transaction are 0 shares, but it does not disclose reasons, tax considerations, or whether other insiders/funds are changing positions concurrently.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-11; sale executed 2026-06-10 to 2026-06-11.

Background

This is an SEC Form 4 insider transaction disclosure for LEVI, reported via SEC EDGAR.

Company-level read

Ticker impact

$LEVINeutralMedium confidence
Context

10% owner Robert Haas sold 492,033 LEVI shares in open-market transactions ($11.86M) under a pre-arranged 10b5-1 plan.

Expected impact

Low-to-moderate downside bias for short-term sentiment; likely limited fundamental impact.

Evidence & confidence

The filing is a primary-source Form 4 showing size ($11.86M) and role (10% owner), but it explicitly states a pre-arranged 10b5-1 plan, which typically dampens interpretive strength.

Market effects

No direct sector read-through; this is company-specific ownership activity.

None indicated.

None indicated.

Counterpoint

Because the trades were executed under a pre-arranged 10b5-1 plan, the sale may reflect liquidity/portfolio management rather than bearish expectations.

Key entities

  • LEVI STRAUSS & CO

    Issuer of the securities sold by a 10% owner insider.

  • Haas Robert D.

    10% owner who sold 492,033 shares via open-market transactions under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LEVIHighAI 8/10

Levi's CEO admits the company missed the biggest jeans trend of the year

Levi Strauss & Co. (LEVI) CEO Michelle Gass admitted the company missed the U.S. shift to low-rise jeans during the back-to-school season, impacting its direct-to-consumer sales. Despite a 4% revenue increase to $1.6 billion in Q3, shares fell nearly 5%. Levi's has since refocused marketing on low-rise styles and expects full-year revenue growth of about 6%.

$LEVIMed

Levi Strauss CEO Sounds Alarm on Growing Competition in Denim Market

Levi Strauss reported mixed results: European revenue rose 4-5%, Asia saw 5-10% growth, and Signature brand revenue jumped 13%. The company raised its adjusted earnings forecast to $1.54-$1.56 per share but lowered its revenue growth outlook to ~7%. CEO Michelle Gass noted increased competition in the denim market, emphasizing the need for innovation to maintain market share.

$LEVIMed

BNP Paribas Exane raises Levi Strauss price target to $35

BNP Paribas Exane raised its price target for Levi Strauss (LEVI) to $35, citing strong revenue growth and margins. The company reported Q3 revenue of $1.6B, up 4.3%, and EPS of $0.48, beating some estimates. Analysts note challenges in direct-to-consumer sales but see long-term growth potential. Other firms adjusted targets, ranging from $22 to $27.